Table 3. Fate of secondary transplant... | American Society of Hematology

Table 3.

Fate of secondary transplant recipients from primary mice with TEL-ABL–induced small-bowel syndrome and chronic myeloid leukemia–like disease

Primary disease	Secondary disease
Primary disease	Early graft failure	Late graft failure	T-cell lymphoma	Macrophage tumors	Healthy	Not analyzed
SBS (n = 10)	3 (15)	—	2 (153)	2 (175)	2 (293)	1 (225)
Mixed SBS-CML (n = 4)	4 (17)	—	—	—	—	—
CML (n = 20)	4 (17)	2 (91)	4 (193)	5 (95)	2 (272)	3 (250)

Primary disease	Secondary disease
Primary disease	Early graft failure	Late graft failure	T-cell lymphoma	Macrophage tumors	Healthy	Not analyzed
SBS (n = 10)	3 (15)	—	2 (153)	2 (175)	2 (293)	1 (225)
Mixed SBS-CML (n = 4)	4 (17)	—	—	—	—	—
CML (n = 20)	4 (17)	2 (91)	4 (193)	5 (95)	2 (272)	3 (250)

Values are numbers of secondary recipient mice and, in parentheses, the mean number of days of survival after transplantation.